Opinion|Videos|May 1, 2024
New Therapeutic Frontiers in PAH
Author(s)Ronald Oudiz, MD, FACP, FACC, FCCP
A cardiovascular specialist provides an overview of emerging therapies and targets in the PAH treatment space and how they address current unmet needs.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What new therapeutic options have emerged in the pulmonary arterial hypertension (PAH) treatment landscape, and what are their mechanisms of action and potential benefits?
- How do emerging therapies address the unmet needs in PAH management, such as improving symptom control, slowing disease progression, or targeting specific pathways?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV
2
Ocrelizumab Led to Declines in Immunoglobulins in Patients With MS
3
Topical Delgocitinib Improves Chronic Hand Eczema Outcomes Across All Trial Timepoints
4
The Oncology Care Model: A Decade of Transformation
5